Calton & Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.09M | Buy |
+27,870
| New | +$4.3M | 0.59% | 38 |
|
|
2025
Q4 | – | Sell |
-29,256
| Closed | -$4.07M | – | 490 |
|
|
2025
Q3 | $4.07M | Buy |
29,256
+902
| +3% | +$122K | 0.61% | 35 |
|
|
2025
Q2 | $3.82M | Buy |
28,354
+32
| +0.1% | +$4.32K | 0.66% | 34 |
|
|
2025
Q1 | $4.14M | Buy |
28,322
+9,858
| +53% | +$1.43M | 0.94% | 23 |
|
|
2024
Q4 | $2.54M | Buy |
18,464
+2,138
| +13% | +$313K | 1.12% | 18 |
|
|
2024
Q3 | $2.51M | Buy |
16,326
+3,136
| +24% | +$475K | 0.96% | 24 |
|
|
2024
Q2 | $1.92M | Sell |
13,190
-1,504
| -10% | -$216K | 0.96% | 24 |
|
|
2024
Q1 | $2.17M | Sell |
14,694
-18,119
| -55% | -$2.6M | 1.06% | 20 |
|
|
2023
Q4 | $4.47M | Buy |
32,813
+24,253
| +283% | +$3.16M | 1.8% | 10 |
|
|
2023
Q3 | $1.1M | Sell |
8,560
-29,745
| -78% | -$3.95M | 1.61% | 15 |
|
|
2023
Q2 | $5.08M | Sell |
38,305
-4,359
| -10% | -$575K | 2.37% | 6 |
|
|
2023
Q1 | $5.52M | Sell |
42,664
-13,892
| -25% | -$1.81M | 2.56% | 4 |
|
|
2022
Q4 | $7.68M | Buy |
56,556
+7,612
| +16% | +$1.01M | 2.97% | 2 |
|
|
2022
Q3 | $5.93M | Buy |
48,944
+9,537
| +24% | +$1.23M | 3.39% | 2 |
|
|
2022
Q2 | $5.05M | Buy |
39,407
+2,115
| +6% | +$277K | 2.81% | 3 |
|
|
2022
Q1 | $5.11M | Sell |
37,292
-420
| -1% | -$55.6K | 1.52% | 11 |
|
|
2021
Q4 | $5.31M | Buy |
37,712
+4,309
| +13% | +$572K | 1.42% | 11 |
|
|
2021
Q3 | $4.25M | Sell |
33,403
-1,752
| -5% | -$232K | 0.93% | 18 |
|
|
2021
Q2 | $4.43M | Sell |
35,155
-1,839
| -5% | -$225K | 0.84% | 23 |
|
|
2021
Q1 | $4.32M | Sell |
36,994
-13,625
| -27% | -$1.57M | 0.84% | 21 |
|
|
2020
Q4 | $5.74M | Sell |
50,619
-5,097
| -9% | -$556K | 1.02% | 16 |
|
|
2020
Q3 | $5.88M | Buy |
55,716
+1,048
| +2% | +$110K | 1.21% | 14 |
|
|
2020
Q2 | $5.47M | Buy |
54,668
+11,299
| +26% | +$1.12M | 1.19% | 14 |
|
|
2020
Q1 | $3.84M | Buy |
43,369
+5,552
| +15% | +$539K | 0.95% | 17 |
|
|
2019
Q4 | $3.85M | Buy |
37,817
+23,307
| +161% | +$2.24M | 0.77% | 21 |
|
|
2019
Q3 | $1.31M | Buy |
14,510
+3,555
| +32% | +$325K | 0.29% | 67 |
|
|
2019
Q2 | $1.01M | Sell |
10,955
-256
| -2% | -$23K | 0.29% | 70 |
|
|
2019
Q1 | $1.03M | Sell |
11,211
-1,122
| -9% | -$101K | 0.31% | 60 |
|
|
2018
Q4 | $1.07M | Buy |
12,333
+1,249
| +11% | +$113K | 0.39% | 52 |
|
|
2018
Q3 | $1.05M | Sell |
11,084
-95
| -0.8% | -$8.58K | 0.31% | 58 |
|
|
2018
Q2 | $1.01M | Buy |
11,179
+1,177
| +12% | +$97.5K | 0.29% | 60 |
|
|
2018
Q1 | $814K | Sell |
10,002
-612
| -6% | -$52.1K | 0.24% | 90 |
|
|
2017
Q4 | $940K | Buy |
+10,614
| New | +$875K | 0.24% | 77 |
|
Other funds holding XLV
Calton & Associates's XLV Position: Q1 2026 in Review
Calton & Associates opened a new position in State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2026: 27,870 shares worth $4.09M. The stake represents 0.59% of the portfolio and ranks #38 among its holdings. This is a return to the name: Calton & Associates previously reported a position in XLV as recently as Q3 2025.
Calton & Associates first reported a position in XLV in Q4 2017 and has held it in 33 quarters since. The position peaked at $7.68M in Q4 2022. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- Calton & Associates held 27,870 shares of State Street Health Care Select Sector SPDR ETF worth $4.09M as of Q1 2026.
- State Street Health Care Select Sector SPDR ETF was a new Calton & Associates position in Q1 2026.
- State Street Health Care Select Sector SPDR ETF made up 0.59% of Calton & Associates's portfolio in Q1 2026, its #38 holding.
- Calton & Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2017 and has held it in 33 quarters since.
- Calton & Associates's State Street Health Care Select Sector SPDR ETF position peaked at $7.68M in Q4 2022.
- 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.